세균성 질환 진단 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Bacterial Disease Diagnostics Market size is expected to reach USD 8.58 Billion in 2034 from USD 4.25 Billion (2025) growing at a CAGR of 8.12% during 2026-2034.

The global bacterial disease diagnostics market is growing steadily due to the increasing burden of bacterial infections and the rising demand for rapid and accurate diagnostic solutions. Hospitals and laboratories are increasingly adopting advanced diagnostic tools to identify bacterial pathogens quickly and guide appropriate treatment. The growing awareness about antimicrobial resistance is also encouraging healthcare providers to adopt precise diagnostic methods.

Technological advancements such as molecular diagnostics, polymerase chain reaction (PCR), and automated testing systems are significantly improving the efficiency and accuracy of bacterial disease detection. Government initiatives promoting early disease diagnosis and investments in healthcare research are further supporting market growth. Additionally, the expansion of diagnostic laboratories and the increasing adoption of point-of-care testing are contributing to the rising demand for bacterial diagnostics.

In the future, the market is expected to benefit from innovations in rapid diagnostic technologies and the integration of artificial intelligence in diagnostic systems. The increasing focus on personalized medicine and targeted treatment approaches will further strengthen demand for accurate bacterial detection methods. Emerging economies are also expected to create new growth opportunities as healthcare infrastructure continues to expand.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Diagnostic Kits
• Instruments
• Reagents And Consumables

By Test Type

• Culture-Based Tests
• Microscopy
• Biochemical Tests
• Molecular Tests
• Serological Tests

By Technology

• Polymerase Chain Reaction (PCR)
• Enzyme-Linked Immunosorbent Assay (ELISA)
• Next-Generation Sequencing (NGS)
• Matrix-Assisted Laser Desorption Time of Flight (MALDI-TOF) Mass Spectrometry
• Microarray Technology
• Culturing Techniques
• Others (Nanopore Sequencing, etc.)

By Sample Type

• Blood
• Urine
• Sputum
• Stool
• Cerebrospinal Fluid (CSF)
• Others (Tissue Sample, etc.)

By Application

• Respiratory Infections
• Gastrointestinal Infections
• Urinary Tract Infections (UTIs)
• Sexually Transmitted Infections (STIs)
• Hospital-acquired Infections (HAIs)
• Others (Skin Infections, etc.)

By End-user

• Hospitals & Ambulatory Surgical Centers
• Diagnostic Laboratories
• Academic & Research Institutes
• Others (Clinics, etc.)

COMPANIES PROFILED

• Abbott, Siemens Healthineers, Becton Dickinson and Company, Quest Diagnostics, QuidelOrtho Corporation, Sysmex Corporation, Danaher Corporation, QIAGEN NV, BioRad Laboratories Inc, Revvity, DiaSorin SpA, Thermo Fisher Scientific Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BACTERIAL DISEASE DIAGNOSTICS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Diagnostic Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Reagents And Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BACTERIAL DISEASE DIAGNOSTICS MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Test Type
• 5.2. Culture-Based Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Microscopy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Biochemical Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Molecular Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Serological Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BACTERIAL DISEASE DIAGNOSTICS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Technology
• 6.2. Polymerase Chain Reaction (PCR) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Enzyme-Linked Immunosorbent Assay (ELISA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Next-Generation Sequencing (NGS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Matrix-Assisted Laser Desorption Time of Flight (MALDI-TOF) Mass Spectrometry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Microarray Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Culturing Techniques Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.8. Others (Nanopore Sequencing, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BACTERIAL DISEASE DIAGNOSTICS MARKET: BY SAMPLE TYPE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Sample Type
• 7.2. Blood Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Urine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Sputum Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Stool Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Cerebrospinal Fluid (CSF) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.7. Others (Tissue Sample, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BACTERIAL DISEASE DIAGNOSTICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Application
• 8.2. Respiratory Infections Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Gastrointestinal Infections Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Urinary Tract Infections (UTIs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Sexually Transmitted Infections (STIs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.6. Hospital-acquired Infections (HAIs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.7. Others (Skin Infections, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL BACTERIAL DISEASE DIAGNOSTICS MARKET: BY END-USER 2022-2034 (USD MN)

• 9.1. Market Analysis, Insights and Forecast End-user
• 9.2. Hospitals & Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.4. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.5. Others (Clinics, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 10. GLOBAL BACTERIAL DISEASE DIAGNOSTICS MARKET: BY REGION 2022-2034 (USD MN)

• 10.1. Regional Outlook
• 10.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.2.1 By Product Type
  • 10.2.2 By Test Type
  • 10.2.3 By Technology
  • 10.2.4 By Sample Type
  • 10.2.5 By Application
  • 10.2.6 By End-user
  • 10.2.7 United States
  • 10.2.8 Canada
  • 10.2.9 Mexico
• 10.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.3.1 By Product Type
  • 10.3.2 By Test Type
  • 10.3.3 By Technology
  • 10.3.4 By Sample Type
  • 10.3.5 By Application
  • 10.3.6 By End-user
  • 10.3.7 United Kingdom
  • 10.3.8 France
  • 10.3.9 Germany
  • 10.3.10 Italy
  • 10.3.11 Russia
  • 10.3.12 Rest Of Europe
• 10.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.4.1 By Product Type
  • 10.4.2 By Test Type
  • 10.4.3 By Technology
  • 10.4.4 By Sample Type
  • 10.4.5 By Application
  • 10.4.6 By End-user
  • 10.4.7 India
  • 10.4.8 Japan
  • 10.4.9 South Korea
  • 10.4.10 Australia
  • 10.4.11 South East Asia
  • 10.4.12 Rest Of Asia Pacific
• 10.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.5.1 By Product Type
  • 10.5.2 By Test Type
  • 10.5.3 By Technology
  • 10.5.4 By Sample Type
  • 10.5.5 By Application
  • 10.5.6 By End-user
  • 10.5.7 Brazil
  • 10.5.8 Argentina
  • 10.5.9 Peru
  • 10.5.10 Chile
  • 10.5.11 Rest of Latin America
• 10.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.6.1 By Product Type
  • 10.6.2 By Test Type
  • 10.6.3 By Technology
  • 10.6.4 By Sample Type
  • 10.6.5 By Application
  • 10.6.6 By End-user
  • 10.6.7 Saudi Arabia
  • 10.6.8 UAE
  • 10.6.9 Israel
  • 10.6.10 South Africa
  • 10.6.11 Rest of the Middle East And Africa

Chapter 11. COMPETITIVE LANDSCAPE

• 11.1. Recent Developments
• 11.2. Company Categorization
• 11.3. Supply Chain & Channel Partners (based on availability)
• 11.4. Market Share & Positioning Analysis (based on availability)
• 11.5. Vendor Landscape (based on availability)
• 11.6. Strategy Mapping

Chapter 12. COMPANY PROFILES OF GLOBAL BACTERIAL DISEASE DIAGNOSTICS INDUSTRY

• 12.1. Top Companies Market Share Analysis
• 12.2. Company Profiles
  • 12.2.1 Abbott
  • 12.2.2 Siemens Healthineers
  • 12.2.3 Becton Dickinson And Company
  • 12.2.4 Quest Diagnostics
  • 12.2.5 QuidelOrtho Corporation
  • 12.2.6 Sysmex Corporation
  • 12.2.7 Danaher Corporation
  • 12.2.8 QIAGEN N.V
  • 12.2.9 Bio-Rad Laboratories Inc
  • 12.2.10 Revvity
  • 12.2.11 DiaSorin S.p.A
  • 12.2.12 Thermo Fisher Scientific Inc